KARYOPHARM THERAPEUTICS INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$0.66
-24.76%
Alpha Vantage · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
-23.6%
3 months
-66.4%
6 months
-92.5%
1 year
-88.9%
Year to date
-91.0%
52-week range
$0.32 – $10.67
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$15M
P/E
-0.1
P/B
0
P/S
0.1
Revenue
$146.62M
Net income
-$224.74M
Diluted EPS
-14.38
Gross margin
95.90%
Net margin
-153.30%
Return on equity
77.60%
Total debt
$256.19M
Cash
$55.3M
Free cash flow
-$65.35M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | $33.43M | -$67.02M | 96.80% | -200.50% | -$24.93M |
| Mar 31, 2026 | $35.07M | -$22.39M | 96.20% | -63.90% | -$22.73M |
| Dec 31, 2025 | $34.08M | -$102.2M | 95.60% | -299.90% | -$11.83M |
| Sep 30, 2025 | $44.04M | -$33.13M | 95.20% | -75.20% | -$5.86M |
| Jun 30, 2025 | $37.93M | -$37.25M | 97.20% | -98.20% | -$18.7M |
| Mar 31, 2025 | $30.02M | -$23.46M | 95.70% | -78.20% | -$38.98M |
| Dec 31, 2024 | $30.54M | -$30.78M | 95.60% | -100.80% | -$25.76M |
| Sep 30, 2024 | $38.78M | -$32.07M | 96.60% | -82.70% | -$19.45M |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent KPTI news
All market newsNo ticker-linked stories are in the current archive.